Queen's University at Kingston, commonly known as Queen's University or simply Queen's, is a public research university in Kingston, Ontario, Canada. Queen's holds more than 1,400 hectares of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England.

During the past decade, Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital" #1 collaborator was "Heart and Stroke Foundation of Canada" with 1 trials as a collaborator, "Lantheus Medical Imaging" with 1 trials as a collaborator and "Queen's University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital" are "Acute Coronary Syndrome" (1 trials), "Atheroma" (1 trials), "Atherosclerosis" (1 trials), "Cardiac Disease" (1 trials) and "Metabolic Syndrome" (1 trials). Many other conditions were trialed in "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital" in a lesser frequency.

Most popular intervention types in "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital" are "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cellulose capsules" (1 trials), "L-carnitine capsules" (1 trials) and "Ultrasound" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".